Biogen agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion, expanding its portfolio in immunology and rare-disease medicines.
Source link
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
Date:
More like thisRelated
Billionaire’s son offers home for Colombia’s “cocaine hippos” rather than have them killed
An Indian billionaire's son offered...
Hemp industry in court to argue for an extended pause on intoxicating hemp ban
A temporary restraining order to prevent the enforcement of...
Gavin Adcock Just Relaunched His Zach Bryan Beef
Things have been pretty quiet between Zach Bryan and...